Morningstar

ProImmune Ltd Introduces ProVE® SL Self‑Loading MHC Class I Monomers to Improve T Cell ...

ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE® SL Self-Loading MHC Class I Monomers. The novel reagents for antigen-specific CD8+ T ...
News Medical

Proimmune Ltd introduces Prove® SL Self-Loading MHC Class I Monomers to improve T cell ...

ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE ® SL Self-Loading MHC Class I Monomers. The novel reagents for antigen-specific CD8+ T ...